Stratedigm, Inc. is a Silicon Valley-based startup founded in November 2004 by Rosa Chang and Shervin Javadi. The company focuses on creating customizable, upgradeable, benchtop flow cytometry systems known for their robustness and reliability. Their iterative design process allows for easy field-upgrades, maximizing uptime and budget as they continually improve upon their flow cytometer's design year after year. The cytometers are scalable, automation-ready, and can analyze particles ranging from 0.2 µm to 7.0 µm in the same sample, catering to demanding applications like microparticles. Additionally, the company offers an automation suite orchestrated under one software package, ensuring user-friendly and approachable operation. Stratedigm's commitment to reliability, performance, and exceptional customer care is intrinsic to their core beliefs and practices. The company stands behind the longevity and support of their lab equipment, making it a reliable investment. Notably, as long as a Stratedigm flow cytometer is under service contract, customers are guaranteed continuous support. In essence, Stratedigm's focus on pairing cutting-edge technology in an affordable, compact package with truly customer-centric care demonstrates their commitment to "cytometry without compromise." The company's dedication to innovation and customer satisfaction positions them as an attractive prospect for potential investors in the automation and biotechnology industries.
There is no investment information
No recent news or press coverage available for Stratedigm, Inc..